Showing results (591-600 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|April 19, 2008
Effect of BCG stimulus on proinflammatory cytokine production in laryngeal cancerLuiz Carlos Conti-Freitas, Maria Cristina Foss-Freitas, Rui Celso Martins Mamede, et al.Cancer Immunology, Immunotherapy : CII|June 5, 2008
Potential immunologic effects of statins in cancer following transplantationJ E Fildes, S M Shaw, S G Williams, et al.Cancer Immunology, Immunotherapy : CII|June 5, 2008
MHC-dependent desensitization of intrinsic anti-self reactivityCristan M Jubala, Angela R Lamerato-Kozicki, Michelle Borakove, et al.Cancer Immunology, Immunotherapy : CII|August 28, 2019
Safety and efficacy of PD-1 blockade-activated multiple antigen-specific cellular therapy alone or in combination with apatinib in patients with advanced solid tumors: a pooled analysis of two prospective trialsLijun Liang, Yixuan Wen, Rong Hu, et al.Cancer Immunology, Immunotherapy : CII|September 7, 2019
Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancerYuping D Li, Jonathan B Lamano, Jason B Lamano, et al.Cancer Immunology, Immunotherapy : CII|August 25, 2019
Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancerMohamed Badr, Korinna Jöhrens, Michael Allgäuer, et al.Cancer Immunology, Immunotherapy : CII|August 27, 2019
CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse modelsBjarne Bogen, Marte Fauskanger, Ole Audun Haabeth, et al.Cancer Immunology, Immunotherapy : CII|September 13, 2019
Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppressionVasiliki Siozopoulou, Elly Marcq, Julie Jacobs, et al.Cancer Immunology, Immunotherapy : CII|September 14, 2019
Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signatureEmily Hinchcliff, Cherie Paquette, Jason Roszik, et al.Cancer Immunology, Immunotherapy : CII|January 24, 1998
Co-expression of immunogenic determinants by the same cellular immunogen is required for the optimum immunotherapeutic benefit in mice with melanomaW Xu, E de Zoeten, V Carr-Brendel, et al.Pageof 650